The LAMEA Medical Hyperspectral Imaging Systems Market would witness market growth of 13.9% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Medical Hyperspectral Imaging Systems Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $149 Million by 2031. The Argentina market is showcasing a CAGR of 14.6% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 13.5% during (2024 - 2031).
In oncology, the use of hyperspectral imaging systems for early detection, diagnosis, as well as treatment monitoring of diverse forms of cancer is on the rise. The ability of hyperspectral imaging to differentiate between healthy and diseased tissues based on their spectral signatures presents significant growth opportunities in oncology. Cancer is the leading cause of death, accounting for approximately 10 million deaths in 2020, or almost one in every six deaths, according to the WHO. Cancers of the prostate, breast, lungs, colon, and rectum are the most common.
In dermatology, these imaging systems are also finding growing applications. They are used for the early detection and diagnosis of skin conditions such as melanoma and psoriasis. The non-invasive nature of hyperspectral imaging makes it particularly attractive for dermatological applications, driving growth opportunities in this field. These imaging systems are also used in surgical settings to provide real-time, high-resolution images of tissues during procedures. This facilitates the navigation of intricate anatomical structures by surgeons with enhanced accuracy, resulting in improved patient outcomes and offering substantial prospects for advancement in the domain of surgery.
Chronic diseases often require long-term management and monitoring, which can necessitate frequent diagnostic imaging procedures. According to the World Health Organization (WHO), cardiovascular disease is the leading cause of NCD deaths in the UAE, accounting for 34 percent of all deaths in the country, followed by cancer (12 percent). The four main NCDs kill around 4,800 people in the UAE per year, and the chance of dying before the age of 70 from NCDs is nearly one in five. As the prevalence of chronic diseases rises in the UAE, there may be an increased demand for advanced diagnostic tools like hyperspectral imaging systems to aid in the early detection, diagnosis, and monitoring of these conditions. In conclusion, high healthcare budget and increasing prevalence of chronic disease in the region is propelling the growth of the market.
Based on Product, the market is segmented into Hyperspectral Camera, and Accessories. Based on Technology, the market is segmented into Snapshot, Push Broom, and Others. Based on Application, the market is segmented into Medical Diagnostics, Quality Assurance & Drug Testing, and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research & Academic Institutes. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Brazil market dominated the LAMEA Medical Hyperspectral Imaging Systems Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $149 Million by 2031. The Argentina market is showcasing a CAGR of 14.6% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 13.5% during (2024 - 2031).
In oncology, the use of hyperspectral imaging systems for early detection, diagnosis, as well as treatment monitoring of diverse forms of cancer is on the rise. The ability of hyperspectral imaging to differentiate between healthy and diseased tissues based on their spectral signatures presents significant growth opportunities in oncology. Cancer is the leading cause of death, accounting for approximately 10 million deaths in 2020, or almost one in every six deaths, according to the WHO. Cancers of the prostate, breast, lungs, colon, and rectum are the most common.
In dermatology, these imaging systems are also finding growing applications. They are used for the early detection and diagnosis of skin conditions such as melanoma and psoriasis. The non-invasive nature of hyperspectral imaging makes it particularly attractive for dermatological applications, driving growth opportunities in this field. These imaging systems are also used in surgical settings to provide real-time, high-resolution images of tissues during procedures. This facilitates the navigation of intricate anatomical structures by surgeons with enhanced accuracy, resulting in improved patient outcomes and offering substantial prospects for advancement in the domain of surgery.
Chronic diseases often require long-term management and monitoring, which can necessitate frequent diagnostic imaging procedures. According to the World Health Organization (WHO), cardiovascular disease is the leading cause of NCD deaths in the UAE, accounting for 34 percent of all deaths in the country, followed by cancer (12 percent). The four main NCDs kill around 4,800 people in the UAE per year, and the chance of dying before the age of 70 from NCDs is nearly one in five. As the prevalence of chronic diseases rises in the UAE, there may be an increased demand for advanced diagnostic tools like hyperspectral imaging systems to aid in the early detection, diagnosis, and monitoring of these conditions. In conclusion, high healthcare budget and increasing prevalence of chronic disease in the region is propelling the growth of the market.
Based on Product, the market is segmented into Hyperspectral Camera, and Accessories. Based on Technology, the market is segmented into Snapshot, Push Broom, and Others. Based on Application, the market is segmented into Medical Diagnostics, Quality Assurance & Drug Testing, and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research & Academic Institutes. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Specim, Spectral Imaging Ltd. (Konica Minolta, Inc.)
- XIMEA Group
- ClydeHSI
- Diaspective Vision GmbH
- Cubert GmbH
- HyperMed Imaging, Inc.
- Headwall Photonics, Inc.
- Resonon Inc.
- BaySpec, Inc.
- Imec VZW
Market Report Segmentation
By Product- Hyperspectral Camera
- Accessories
- Snapshot
- Push Broom
- Others
- Medical Diagnostics
- Quality Assurance & Drug Testing
- Others
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Research & Academic Institutes
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Medical Hyperspectral Imaging Systems Market by Product
Chapter 5. LAMEA Medical Hyperspectral Imaging Systems Market by Technology
Chapter 6. LAMEA Medical Hyperspectral Imaging Systems Market by Application
Chapter 7. LAMEA Medical Hyperspectral Imaging Systems Market by End-use
Chapter 8. LAMEA Medical Hyperspectral Imaging Systems Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Specim, Spectral Imaging Ltd. (Konica Minolta, Inc.)
- XIMEA Group
- ClydeHSI
- Diaspective Vision GmbH
- Cubert GmbH
- HyperMed Imaging, Inc.
- Headwall Photonics, Inc.
- Resonon Inc.
- BaySpec, Inc.
- Imec VZW
Methodology
LOADING...
